Tier 1 Product definition

Tier 1 Product means any product in any form or formulation that contains or incorporates a Program Compound described in Section 1.42(a).
Sample 1
Tier 1 Product shall have the meaning set forth in Section 8.3.1.
Sample 1
Tier 1 Product means any pharmaceutical compound or product that is listed hereafter or contains the compounds listed hereafter as an active ingredient: [ ].
Sample 1

Examples of Tier 1 Product in a sentence

  • Any Tier 1 Product Support Specialist or Tier 2 Platform Support Specialist who attains a Web Systems certification (CIW Level 1), a specified Mac certification and/or Linux+ certifications shall receive a weekly differential of $35.00 for certification achieved.

  • During the forty-five (45)-day period following availability of the Data Room, Synosia shall, at Xxxxx’x request, permit Roche to review the information in the Data Room and conduct discussions with appropriate personnel of Synosia on the Tier 1 Product.

  • For clarity, if either a Tier 1 Product [***] or an Optioned Tier 2 Product [***] achieves the “[***]” milestone, then the same Tier 1 Product [***] or Optioned Tier 2 Product [***] is eligible to achieve the “[***]” only if (i) such [***] is tested in an [***] tested in achieving the “[***]” milestone and (ii) such “[***]” milestone has not already been achieved by the applicable Tier 1 Product or Optioned Tier 2 Product [***].

  • In any Calendar Quarter during the Royalty Term for which there is no longer a Valid Claim of the CAMP4-Assignee Patents that Covers a given Tier 1 Product in a country, the Royalty rates provided in Section 4.3 for such Tier 1 Product will be reduced in such country by [***] for such Calendar Quarter.

  • In addition, unless and until the earlier of (i) Synosia’s exercise of its termination rights under Section 10.3(c), and (ii) Roche’s exercise of its Opt-In Right, Synosia shall use Commercially Reasonable Efforts to develop and commercialize (directly and/or through one or more Affiliates or sublicensees) at least one Tier 1 Product in the United States and Europe and in such other markets in the Territory as Synosia deems commercially reasonable.

  • In the event that Fulcrum determines that a Tier 1 Product cannot be advanced despite the exercise of Commercially Reasonable Efforts, Fulcrum shall use Commercially Reasonable Efforts to Develop a Tier 2 Product.

  • By way of example, if annual global Net Sales of a given Tier 1 Product are less than [***], and the reduction set forth in Section 4.4.4 has operated to reduce the royalty rate from [***]% to [***]%, when there is no longer a Valid Claim Covering such Tier 1 Product the royalty rate shall only drop to [***]% for the remaining duration of the Royalty Term for such Tier 1 Product.

  • Payment tiers: Tier 1 (Product Code on invoice DEFRA0023) =£350 Tier 2 (Product Code on invoice DEFRA0024) = £2350 Tier 3 (Product Code on invoice DEFRA0025) = £800 Please tick the relevant box below for payment method.

  • Tier 1: Product + FinishingSalient risks in tier 1 include: Non-payment of minimum wages Payment of recruitment fees and other forms of debt-bondage Violence in the workplace Limitations on freedom of movement Forced overtime Contract substitution Document retention Exploitation and/or discrimination of migrant workers and other ethnic minorities We take a comprehensive approach to monitoring and building the capacity of tier 1 factories.

  • If such rights are reacquired by either Party, EuroGen shall bear the full cost and expense of acquiring such rights from Pfizer, and Nipent for all applications shall be considered a Tier 1 Product.


More Definitions of Tier 1 Product

Tier 1 Product means any product which on the Relevant Date is Covered by a Valid Claim of a CAMP4-Assignee Patent. For clarity, Tier 1 Products may or may not be Covered by a Valid Claim of a CMCC-Licensed Patent.
Sample 1
Tier 1 Product means a Licensed Product sold in a country where the Licensed Compound in such Licensed Product is a Tier 1 Compound (i.e., such compound [*] in such country); a “Tier 2 Product” means a Licensed Product sold in a country where the Licensed Compound in such Licensed Product is a Tier 2 Compound (i.e., such compound meets the criteria in subsection 1.14(ii) and is [*] in such country). For the avoidance of doubt, Licensed Product shall not mean foods or dietary supplements.
Sample 1
Tier 1 Product means a Licensed Product that contains a Tier 1 Compound as an active pharmaceutical ingredient.
Sample 1
Tier 1 Product means a Product where (i) the assessment of p53 Status is on the approved label of such Product or (ii) Xxxxx (or its Sublicensee) Sells a [***], or (iii) Xxxxx (or its Sublicensee) requires or recommends that [***]; provided however [***].
Sample 1

Related to Tier 1 Product

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Therapeutically equivalent drug products means drug products that contain the same active ingredients and are identical in strength or concentration, dosage form, and route of administration and that are classified as being therapeutically equivalent by the U.S. Food and Drug Administration pursuant to the definition of "therapeutically equivalent drug products" set forth in the most recent edition of the Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the "Orange Book."

  • Combination Product means any combination of the Product with one (1) or more other active ingredients, products or services that is not the Product, where such products are sold either as a fixed dose/unit or as separate doses/units in a single package for a single price.

  • Licensed Compound means [***].

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Exempt compound means the same as defined in Rule 2.

  • Approved Product means any water fitting, plumbing product, material or component which is the subject of an existing WRAS Approval;

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Designated country end product means a WTO GPA country end product, a Free Trade Agreement country end product, a least developed country end product, or a Caribbean Basin country end product.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • cosmetic product means any substance or mixture intended to be placed in contact with the external parts of the human body (epi­ dermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, protecting them, keeping them in good condition or correcting body odours;

  • Nondesignated country end product means any end product that is not a U.S.-made end product or a designated country end product.